Announcements Trials
Browse Landscape

Phase

Phase 2 40Phase 3 13Phase 1 7Phase 1/2 4Phase 2/3 3

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 1Colorectal Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × titanium silicide × Clear all
NCT05065957 2025-04-30

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

InnoPharmax Inc.

Phase 2/3 Recruiting
180 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT00284258 2012-11-02

Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

Taiho Pharmaceutical Co., Ltd.

Phase 2/3 Completed
426 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00639327 2011-06-28

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Japan Clinical Cancer Research Organization

Phase 2/3 Completed
300 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡